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Department of Chemistry, University of Massachusetts Amherst, Amherst, MassachusettsABSTRACT Proteases are one of the most important and historically utilized classes of drug targets. To effectively interrogate
this class of proteins, which encodes nearly 2% of the human proteome, it is necessary to develop effective and cost-efficient
methods that report on their activity both in vitro and in vivo. We have developed a robust reporter of caspase proteolytic activity,
called caspase-activatable green fluorescent protein (CA-GFP). The caspases play central roles in homeostatic regulation, as
they execute programmed cell death, and in drug design, as caspases are involved in diseases ranging from cancer to neuro-
degeneration. CA-GFP is a genetically encoded dark-to-bright fluorescent reporter of caspase activity in in vitro, cell-based, and
animal systems. Based on the CA-GFP platform, we developed reporters that can discriminate the activities of caspase-6 and -7,
two highly related proteases. A second series of reporters, activated by human rhinovirus 3C protease, demonstrated that we
could alter the specificity of the reporter by reengineering the protease recognition sequence. Finally, we took advantage of the
spectrum of known fluorescent proteins to generate green, yellow, cyan, and red reporters, paving the way for multiplex protease
monitoring.INTRODUCTIONProteases are at the center of several of the most critical
cellular cycles and pathways and are among the most
common targets for drug design (for review see (1)].
Although they have been widely studied and targeted, a
full understanding of the unique biological functions of
related proteases has been very difficult to achieve. Tools
to monitor and catalog the unique biological roles of all
cellular proteases in a spatiotemporal manner are essential
to a complete understanding of proteases and the degradome
they control.
The use of genetically encoded fluorescent reporters has
become increasingly important in the study of proteolytic
activity both in vitro and in vivo because activity can be
monitored as a function of both time and location in living
organisms (for review, see Turk (2)). Current technologies
for studying protease activity in a native cellular context
also include fluorescence resonance energy transfer, lucif-
erase, and positron emission reporters; however, each
approach comes with certain limitations to its applications.
To address some of these shortcomings, we recently
developed a genetically encoded, dark-to-bright reporter
of caspase proteolytic activity (3). This reporter is multi-
functional in that it can be used both in vitro and in vivo
and in bacterial and mammalian systems to indicate the
activity of apoptotic caspases. Although the fluorescent
signal was shown to be significantly higher in the bacterial
system, the 3-fold increase in signal over background inSubmitted November 2, 2012, and accepted for publication January 29,
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0006-3495/13/04/1605/10 $2.00mammalian cells is higher than that observed for compa-
rable genetically encoded reporters. We designed a cas-
pase-activatable (CA) reporter by fusing green fluorescent
protein (GFP; S65T) through a flexible linker containing
the caspase-3 and -7 recognition sequence DEVD to a hydro-
phobic 27-amino-acid peptide on the C-terminus (Fig. 1).
The presence of this peptide inhibits maturation of the chro-
mophore in GFP until it is removed in the presence of an
active caspase. The presence of active caspases even in
healthy cell cultures does lead to higher levels of back-
ground; nevertheless, the significant difference in signal
from cells undergoing apoptosis even over this background
makes CA-GFP a powerful tool for observing cell death.
Given the functional success of CA-GFP for reporting
caspase activity in global apoptosis, we sought to take
advantage of this platform and develop a robust series of
reporters that would enable a number of new protease re-
porting applications. We designed a new series of reporters
to distinguish the activity of closely related caspases and
found that these reporters could also be adapted to function-
ally monitor the activity of unrelated proteases. Initially we
targeted two closely related caspases, caspase-6 and cas-
pase-7 (both clan CD proteases), as well as the human rhino-
virus-14 3C (hRV3C) protease (clan CB).
The caspases are central to the critical process of
apoptosis or programmed cell death, but some caspases
are also involved in inflammation and other biological
processes. Thus, there has been significant interest in har-
nessing the cell-killing power of apoptotic proteases for
applications such as treatment of cancer. If any one caspase
or subset of caspases is to be effectively targeted therapeu-
tically without unwanted effects, it is essential to ensure
that the unique roles of that particular caspase have
been unambiguously uncovered. Up to now, it has beenhttp://dx.doi.org/10.1016/j.bpj.2013.01.058
TABLE 1 GFP-Based Protease Reporters
Version of GFP
reporter
Linker
sequence
Intended
protease
Additional
mutations
CA-GFP DEVDYFQGP caspase-7
C7A-GFPe or
DEVDF-GFPe
DEVDYFQGP caspase-7 D27E
VEIDF-GFP VEIDYFQGP caspase-6
VEIDF-GFPe VEIDYFQGP caspase-6 D27E
C6A-GFPe or
VEIDG-GFPe
VEIDYGQGP caspase-6 D27E
VEIDE-GFPe VEIDYEQGP caspase-6 D27E
VEIDK-GFPe VEIDYKQGP caspase-6 D27E
LEVLF-GFP LEVLFQYGP hRV3C
LEVLG-GFP LEVLGQYGP hRV3C
DEVLF-GFP DEVLFQYGP hRV3C
DEVLG-GFP DEVLGQYGP hRV3C
EEVLF-GFP EEVLFQYGP hRV3C
DEVEF-GFP DEVEFQYGP hRV3C
DEVEG-GFP DEVEGQYGP hRV3C
DEVCF-GFP DEVCFQYGP hRV3C
DEVSF-GFP DEVSFQYGP hRV3C
VEIDF-GFP VEIDFQYGP hRV3C
PEHDF-GFP PEHDFQYGP hRV3C
LEHDF-GFP LEHDFQYGP hRV3C
LEHDG-GFP LEHDFQYGP hRV3C
HRA-DYKGFP LEVLFQYGP hRV3C Y273, K274 deleted
DEVD* DEVD*
DEVDFQ* DEVDFQ*
LEVL* LEVL*
LEVLFQ* LEVLFQ*
DEVL* DEVL*
DEVLFQ* DEVLFQ*
EEVLFQ* EEVLFQ*
EEVEFQ* EEVEFQ*
VEID* VEID*
CA-CerFP DEVDYFQGP caspase-7 F64L, Y66W, S72A,
Y145A, H148D
CA-CitFP DEVDYFQGP caspase-7 T65G, V68L, Q69M,
DEVD↓FQGP
CA-GFP
1 238 247 274
Quenching PeptideGreen Fluorescent Protein
FIGURE 1 Construct of CA-GFP showing the GFP fused through the
flexible, cleavable linker to the quenching peptide.
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each individual caspase; however, this information poten-
tially can be collected using the genetically encoded
reporters we describe here. When the apoptotic cascade is
activated, initiator caspases (caspase-8 and -9) cleave the
zymogen executioner caspases (caspase-3, -6, and -7) to
form active proteases. Activation of the executioners is the
last irreversible step in the apoptotic cascade, ultimately
leading to cell death. Caspase-6 was recently suggested to
play casual roles in both Alzheimer’s and other neurodeger-
ative diseases. Thus it appears that although caspases-3, -6,
and -7 play overlapping roles in apoptosis, it is their unique
roles (e.g., caspase-6’s role in neurodegeneration) that may
be of the greatest therapeutic interest. Tools that can distin-
guish the roles of individual related proteases are therefore
of great importance.
Viral proteases are important drug targets as well, but
their function must be mapped independently of any cellular
proteases before they can be used therapeutically. Human
rhinovirus is the major viral agent in the common cold.
Currently there are no effective drugs to kill this virus,
and patients only receive symptomatic treatments as the
body fights the infection. The replication and maturation
of the human rhinovirus requires the function of the 3C
protease (hRV3C), which therefore represents a major
drug target (6).
Although many biologically important proteolytic
processes occur as part of a propagating proteolytic chain,
to date, few robust technologies exist that allow simulta-
neous monitoring of the activity of multiple proteolytic
events. An ideal system for monitoring proteolytic behavior
would be one that could be adapted to any protease of
interest and could be made in any color to allow for simul-
taneous monitoring of various members of a proteolytic
cascade. In this work, we demonstrate the steps involved
in engineering CA-GFP to be recognized by both homolo-
gous proteases and distally related proteases. We also
describe our ability to change the color of the fluorescent
reporter. These capabilities position this technology
uniquely to fill a substantial void in protease profiling,
particularly in whole, intact organisms.S72A, T203Y
CA-mNeptune DEVDYFQGP caspase-7 Quenching peptide on
the N-terminus of
mNeptune fluorescent
protein
The caspase reporters were designed to have an overlapping hRV3C
cleavage site as a secondary control for reporter function. The nomenclature
GFPe indicates mutation of D27E to remove the caspase-6 cleavage at the
N-terminus of GFP; Y indicates a cleavage site, * indicates a stop codon.MATERIALS AND METHODS
Molecular cloning
Caspase-6 and hRV3C protease reporters
CA-GFP in pBB75 contains a DEVDFQGP linker as previously described
(3). All of the caspase-6 and hRV3C protease reporter variations, unlessBiophysical Journal 104(7) 1605–1614otherwise specified, are based on this construct. We mutated the DEVDF
sequence in CA-GFP to corresponding sequences by site-directed mutagen-
esis using overlapping inverted primers and amplification of the entire
plasmid, in a manner similar to the QuikChange (Agilent Technologies
Inc., Santa Clara, CA) approach. In all constructs denoted as GFPe (Table 1),
we introduced an additional D27E mutation by site-directed mutagenesis to
eliminate the internal caspase-6 recognition site (VELDG, residues 24–28;
Fig. 2 A) in GFP.
The CA-CerFP construct was developed by replacing the codons for the
following residues in CA-GFP: F64L, S72A, Y66W, Y145A, and H148D.
These substitutions were made through multiple rounds of single-point
mutagenesis using a modified QuikChange (Agilent) protocol with CA-
GFP in pET21b as the template plasmid. The CA-CitFP construct was
also developed using CA-GFP in pET21b as the template plasmid for re-
placing resides T65G, V68L, Q69M, S72A, and T203Y through multiple
rounds of modified QuikChange mutagenesis.
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peptide (M2) region from the CA-GFP gene separately from the mNeptune
gene using twoprimers to amplifyM2and twoprimers to amplifymNeptune.
The mNeptune parent was generated by replacing the codons for M41G,
A45V, S61C, A158C, and Y197F in the mKate2 gene in the pmKate2C
vector (Evrogen Joing Stock Company, Moscow, Russia). The first primer
(P1) annealed to the N-terminal region of the mNeptune genewith the linker
sequence included N-terminal to the mNeptune gene. The second primer
(P2) annealed to the C-terminus of mNeptune and included a stop codon
(UAA) and the restriction site for XhoI. The third primer (P3) included an
NheI restriction enzyme site as well as a 6His sequence and annealed to
theN-terminal region of theM2 portion of the CA-GFP gene. The last primer
(P4) annealed to the C-terminus of M2 and included the same sequence for
the linker as P1, giving primers P1 and P4 a 24 bp overlapping region. The
mNeptune fragment was then amplified using primers P1 and P2, and the
M2 portion was amplified using primers P3 and P4. After gel purification
of the amplified fragments, they were combined and allowed to anneal
through the overlapping region for five PCR cycles before the addition of
primers P2 and P3, which then amplified the full-length gene. The gene
was then ligated into pACYCDuet vector in the NheI and XhoI sites. The
final sequence of the N-terminal peptide and linker, MHHHHHHMCN
DSSDPLVVAASIIGILHLILWILDRLDEVDFQGP, was appended to the
N-terminus of mNeptune. The full-length construct was then further ampli-
fied using PCR and ligated into the EcoRI and NotI sites of pET21b.
Caspase constructs
A constitutive two-chain expression system for caspase-6 as described in
Vaidya et al. (7) was used for all coexpressions with active caspase-6.
The expression construct consists of an Escherichia coli optimized codon
sequence of the full-length caspase-6 in the pET11a vector. The gene is
separated by a stop codon, the ribosome-binding site TATACATATG,
and a start codon inserted after position 179. This allows for homogeneous
expression of active caspase-6. A similar construct was developed for cas-
pase-7, as reported in Witkowski and Hardy (8), in which the caspase-7
gene contained in the plasmid pET23b is separated by a stop codon, ribo-
some-binding site, and start codon inserted after residue 198. This cas-
pase-7 constitutive two-chain sequence was then amplified by PCR and
ligated into the NdeI and SacI restriction enzyme sites of pBB75. The inac-
tive caspase-7 (C186A) expression construct consists of the full-length
human caspase-7 gene with the single-point mutation at the active site in
the pET23b vector. This gene was also amplified via PCR and ligated
into the NdeI and SacI restriction enzyme sites of pBB75.Fluorescence assays in whole cells
Expression constructs for caspase-6 or hRV3C protease reporters contained
in the pBB75 vector (kanamycin (Kan)) were cotransformed into the
BL21(DE3) strain of E. coli with either an active constitutively two-chain
version of caspase-6 (7) in pET11b (ampicillin (Amp)), an hRV3C protease
in GEX-vector (Amp; a gift from M. Romanowski), or an empty pET21b
(Amp) vector as a control. Autoinduction media cultures (2 mL) were inoc-
ulated from a dense 100 mL overnight lysogeny broth (LB; Amp/Kan)
culture with 100 mg/mL Amp and 40 mg/mL Kan, and incubated until
they reached an OD600 of 0.6–0.9. The cultures were then incubated
for 18 h at 16C. Cells from each sample were rinsed with PBS, resus-
pended, and diluted in PBS to a final OD600 of 2.0. Then 200 mL of this
diluted suspension was measured for GFP fluorescence (excitation (Ex.)
475/emission (Em.) 512) in a costar 96-well black plate on a Spectramax
M5 spectrophotometer (Molecular Devices).On-plate fluorescence assays
Protease reporters in pBB75 vector (Kan resistant) were cotransformed with
the corresponding protease constructs in pET vectors (Amp resistant) andincubated in a 2 mL LB culture overnight. Then 0.5 mL of this culture
was inoculated onto a nitrocellulose membrane. The membrane was first
incubated on an LB agar plate containing both Amp and Kan overnight
at 37C. The nitrocellulose membrane was then transferred onto a LB
agar induction plate with 100 mg/ml Amp, 40 mg/ml Kan, and 500 mM iso-
propylthio-b-galactoside (IPTG), and incubated for 6 h at 25C and 24 h at
4C (9). The result was recorded using an InGenius (SynGene, Cambridge,
United Kingdom) gel dock under long-wavelength UV light, and a white
illumination picture was also taken as a control.Western blotting
After the whole-cell fluorescence analysis described above was completed,
samples of the E. coli cell suspension were run on an SDS-PAGE gel. The
gel was then transferred to a PVDF membrane (Millipore, Billerica, MA)
and blotted with an anti-GFP (Millipore) monoclonal mouse primary anti-
body. The Western blots were then treated with anti-mouse IgG alkaline
phosphatase produced in goat (Sigma-Aldrich, St. Louis, MO) and visual-
ized using 1-StepNBT/BCIP (ThermoFisher Scientific Inc.,Waltham,MA).Fluorescence assays in cell lysates
Expression constructs for the fluorescent protein reporters CA-GFP, CA-
CerFP, CA-CitFP, and CA-mNeptune (each in the pET21b vector, which
also contains an Amp resistance gene) were cotransformed via electropora-
tion in the BL21(DE3) strain E. coliwith expression constructs for an active
constitutively two-chain version of caspase-7 or a full-length inactive
version of caspase-7, in which the active-site cysteine had been mutated
to alanine (C186A) in the vector pBB75, which also contains a Kan resis-
tance gene. Then 50 mL LB cultures supplemented with 100 mg/mL Amp
and 40 mg/mL Kan were inoculated with 50 mL from a dense 5 mL over-
night culture and incubated until reaching an OD600 of 0.6. The cultures
were then induced with 1 mM IPTG for 18 h at 25C. From each sample,
800 mL aliquots were taken in duplicate, pelleted by centrifugation, and
resuspended in a solution of 0.5 mg/mL lysozyme and 2 U DNAase. After
lysis with four cycles of freeze-thaw, the supernatant of each sample was
measured for fluorescence. CA-GFP (Ex. 475/Em. 512 nm), CA-CerFP
(Ex. 433/Em. 475 nm), and CA-mNeptune (Ex. 580/Em. 650 nm)
fluorescence measurements were taken in a costar 96-well black plate on
a Molecular Devices Spectramax M5 spectrophotometer. CA-CitFP
(Ex. 515/Em. 529 nm) fluorescence was measured on a JASCO FP-6500
spectrofluorometer using a quartz cell. Although the excitation and emis-
sion wavelengths used are not identical to published values, they were
determined to be the optimum wavelengths for measurements using the
instruments indicated. Fluorescence values were normalized to the total
number of cells in culture, which was estimated from the relative A600 of
each culture.RESULTS AND DISCUSSION
We have previously shown that CA-GFP is a robust, genet-
ically encoded reporter of caspase activity in apoptosis (3).
Here we sought to leverage the desirable attributes of
CA-GFP as a tunable platform to build a family of protease
activatable reporters that could distinguish the activities of
various proteases simultaneously.Development of a caspase-6-activatable GFP
Until very recently, caspase-6 was viewed as being very
structurally and functionally similar to other executionerBiophysical Journal 104(7) 1605–1614
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FIGURE 2 Engineering CA-GFP into C6A-GFP. (A) Comparison of
the whole-cell GFP fluorescence of various C6A-GFP constructs. C6A-
GFP constructs cotransformed into E. coli with either active caspase-6
(gray) or empty pET vector as control (white). The nomenclature
GFPe indicates the mutation of D27E to remove the caspase-6 cleavage
at the N-terminus of GFP. Whole-cell GFP fluorescence was measured.
(B) Western blot of various C6A-GFP constructs against GFP antibody.
(C) GFP contains a caspase-6 recognizable site (VELDYG) at residue 27
near the N-terminus.
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studies have shown that caspase-6 not only populates struc-
turally unique conformations (7,10,11) but also may have
unique nonapoptotic roles in neurodegenerative diseases
(see 4, and see 5). To harness the unique capabilities of these
caspases effectively, it is essential to assess and distinguish
their individual activities in a spatiotemporal manner. CA-
GFP has been shown to be a robust in vivo reporter for
apoptotic caspases both in E. coli and in mammalian cells
(3). Therefore, we thought that if we could adapt CA-GFP
to distinguish caspase-6 activity from caspase-7 activity,
we would be able to further understand and better harness
the unique therapeutic potential of these caspases.
To build a caspase-6-activatable-GFP reporter (C6A-
GFP), we replaced the DEVD linker sequence in CA-GFP
with the caspase-6 recognition sequence VEID (VEIDF-
GFP; Table 1). The resulting construct was dark (nonfluo-
rescent) before cleavage by caspase-6, indicating that the
quenching peptide functioned as expected. However, whenBiophysical Journal 104(7) 1605–1614VEIDF-GFP was cotransformed with active caspase-6 in
E. coli, there was no observable fluorescence (Fig. 2 A).
Although we had previously shown that mature GFP is resis-
tant to cleavage by caspase-6 in vitro (12), Western blot
analysis using an anti-GFP antibody showed a predominant
cleavage event that was not at the expected linker cleavage
site (Fig. 2 B). We compared the cleavage pattern observed
with that of a construct in which a stop codon was inserted
after the VEID in the linker (VEID*; Table 1). We found
that one band resulted from cleavage of the VELDYG
sequence at residue 27 near the N-terminus of GFP (Fig. 2
C), whereas the other band was the result of a double
cleavage at both the N-terminal VELDYG site and linker
VEIDYF site. Interestingly, no protein band with a migration
pattern similar to that of VEID*, corresponding to a single
cleavage solely at the VEIDYF linker, was observed. This
indicates that caspase-6 cleaves the N-terminal VELDYG
site before cleaving the VEIDYF linker. GFP is very sensi-
tive to truncations at either terminus (13), so it was
not surprising that no fluorescence was observed when the
VELDYG was cleaved. Interestingly, we did not observe
cleavage of the N-terminal site at residue 27 when apoptosis
was induced in mammalian cells (3). This is likely due to the
robust activity of caspase-3 and -7 relative to the much
lower level of caspase-6 during staurosporine-induced
apoptosis.
To remove this inactivating cleavage site, Asp-27 was
substituted by Glu (D27E). The resulting VEIDF-GFPe
was also dark before cleavage occurred. When cotrans-
formed with active caspase-6, VEIDF-GFPe showed a small
fluorescence increase (Fig. 2 A). Western blotting with an
anti-GFP antibody showed that VEIDF-GFPe was not effi-
ciently cleaved in the experimental conditions (Fig. 2 B).
In prior VEIDF-GFP/caspase-6 coexpression experiments,
the caspase-6 cleavage of the VEIDYF linker was much
less efficient than cleavage of the N-terminal VELDYG.
The fact that we did not observe any bands representing
a single cleavage at the VEIDYF linker strongly suggested
that caspase-6 cleaves the N-terminal VELDYG site first
and that caspase-6 prefers a glycine at the P10 subsite in
our reporter construct. This observation reflects prior obser-
vations made against peptide substrates in which caspase-6
showed a preference for Gly at P10 (14). In light of this,
we modified the VEIDYF linker in VEIDF-GFPe into
VEIDYG. The resulting VEIDG-GFPe reporter yielded
a much stronger fluorescent signal increase upon coexpres-
sion with active caspase-6 (Fig. 2 B). When we coexpressed
VEIDG-GFPe with an empty pET vector, we found that the
replacement of Phe with Gly led to the increase of the basal
fluorescent level in the reporter. Therefore, we also explored
other options for P10 substitution. Residues including Glu
and Lys are frequently found in the P10 subsite of caspase-
6 protein substrates, but not in caspase-3 and -7 substrates
(15). We hypothesized that substitution of the Phe in the
P10 site with either of these residues would improve the
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ducing Glu or Lys at the P10 neither improved the signal
strength nor decreased the basal fluorescence of the reporter
(Fig. 2 B). Therefore, although P10 Gly increases the basal
fluorescent level in our reporter coexpressed with an empty
pET vector, VEIDG-GFPe is still the best caspase-6 reporter
overall due to the strong increase in signal in the presence of
caspase-6 activity, and we will refer to it from this point on
as C6A-GFPe.C6A-GFPe and CA-GFP distinguish caspase-6
and -7 activities
Although all caspases have very similar catalytic dyad
geometries during substrate cleavage, they each show
unique cleavage site preferences due to the composition of
residues that define the peptide recognition subsites (S1–
S4) (15). The classic substrate recognition sequence for
caspase-6 is VEID, and that for caspase-7 is DEVD. Here
we applied caspase-6 and -7 to CA-GFP (DEVDF-GFP),
C7A-GFPe (DEVDF-GFPe), and C6A-GFPe (VEIDG-
GFPe) to assess the responsiveness of the reporters (Fig. 3
A). Western blot analysis using an anti-GFP antibody
showed that caspase-7 does not efficiently cleave the
VEID recognition sequence in C6A-GFPe (Fig. 3 B).
Thus, it appears that C6A-GFPe is a reasonably good
reporter for caspase-6 activity because caspase-6 triggers
a 3- to 4-fold greater response than caspase-7. As negativeA
B
FIGURE 3 CA-GFP, C7A-GFPe, and C6A-GFPe distinguish caspase-6
and caspase-7 activity. The CA-GFP, C7A-GFPe, and C6A-GFPe reporters
were cotransformed into E. coli with empty pET vector (white), active
caspase-7 (black), and active caspase-6 (gray). (A) Whole-cell fluorescence
measurement of reporters. (B) Western blot analysis is shown using anti-
GFP antibody to determine the cleavage efficiency of the reporters.controls for this system, we developed reporters such as
DEVLF-GFP, which is activated by an orthogonal protease
(hRV3C) but is not activated by caspase-6 or -7 (Fig. S1 in
the Supporting Material).
In the presence of caspase-7, CA-GFP clearly showed
a more pronounced fluorescent increase than C7A-GFPe
(Fig. 3 A). We should note that under our previously re-
ported conditions, CA-GFP was coexpressed with caspase-7
in LB media at 25C, which led to a 45-fold fluorescent
signal increase (3). To consistently coexpress different
proteases and GFP-reporters in E. coli at the same time,
here we found it necessary to optimize the expression condi-
tions for all components. In this work, we performed expres-
sion at 16C in autoinduction media. We observed similar
intensity from the positive signals, though at this lower
temperature the background fluorescence level increased,
which led to a slightly lower increase in fluorescence
(~10-fold here). The D27E mutation in C7A-GFPe appar-
ently affects the signal strength of the reporter. Although
CA-GFP and C6A-GFPe are most responsive to their
cognate enzymes, caspase-6 cleaves a fraction of CA-GFP
and C7A-GFPe at the linker, and caspase-7 also cleaves
a small fraction of the C6A-GFPe at the linker (Fig. 3 B).
This is as expected, because caspases are known to be less
selective toward the P2 and P4 substrate subsite residues.
It is worth noting that in the case of coexpression of cas-
pase-6 and CA-GFP, the fluorescence is much lower
compared with that observed for coexpression with an
empty pET vector. This is because removal of the
N-terminal 27 residues in CA-GFP by caspase-6 prevents
the fluorescence of GFP. We note that this property can be
put to use to increase the stringency and selectivity of
caspase reporters. Caspase-7 cleaves CA-GFP at the
linker, increasing fluorescence, whereas caspase-6 cleaves
at residue 27, which prevents fluorescence. This dual
recognition could prove useful for identifying the ratio of
caspase-6 to caspase-7 activity. This characteristic could
be extraordinarily useful in protease engineering, where
the ratiometric dual recognition could serve as a built-in
counterscreen, dramatically aiding the recovery of proteins
with the desired phenotype. We could also apply both the
CA-GFP and C6A-GFPe in this case, where a lowering of
signal from the C7A-GFPe and an elevated C6A-GFPe
signal would increase the detectability of caspase-6 activity.
Thus, in addition to their ability to robustly distinguish
caspase-6 from caspase-7 activity, these reporters also
have other, more nuanced applications.
The CA-GFP family of reporters has exciting applications
in mammalian cells and whole organisms, as we have shown
previously (3). Apoptotic executioner caspases are capable
of functionally substituting for one another in knockout
and knockdown conditions. This property complicates our
ability to characterize the activity of caspase-6 and -7 in
mammalian cells, which is why we chose to work in the
clean background afforded by bacteria heterologouslyBiophysical Journal 104(7) 1605–1614
1610 Wu et al.expressing capases. Other investigators and we are actively
pursuing the development of small-molecule inhibitors that
are specific for caspase-6 or caspase-7. We look forward to
a time, hopefully in the near future, when small-molecule
inhibitors with sufficient specificity for caspase-6 and -7
are available to allow accurate benchmarking of C6A-GFP
and C7A-GFP in mammalian systems.Engineering new proteolytic recognition: hRV3C
By successfully engineering a caspase-6 reporter, we were
able to gain insight into how the CA-GFP concept could
be adapted to report on other biomedically important prote-
ases. We next introduced the hRV3C protease recognition
sequence into the linker to generate a reporter for hRV3C
(Fig. 4 A). hRV3C has a preferred substrate sequence
of LEVLFQGP (16). Our initial design changed the
DEVDFQGP sequence in CA-GFP to LEVLFQGP, and
thus the sequences of the CA-GFP and LEVLF-GFP
reporters are identical except for the substitution of two
aspartates (D) for the two leucines (L) in the linker. This
LEVLF-GFP reporter showed a moderate (8-fold) increase
in fluorescence upon hRV3C protease coexpression com-A D
E
B
C
Biophysical Journal 104(7) 1605–1614pared with expression with an empty vector or with
caspase-7, which, as expected, was unable to cleave this
linker (Fig. 4 B). Although the fluorescence in the cleaved
hRV3C reporter is significantly higher than background,
the fluorescence increase is much lower than that observed
for CA-GFP coexpressed with caspase-7. The overall fluo-
rescence after cleavage is also very low in comparison
with CA-GFP or C6A-GFPe. We found that this was not
due to a difference in reporter expression levels or to the
completeness of the protease digestion (data not shown).
We reasoned that the difference in fluorescence after
cleavage might be due to the remaining linker residues
that differ from those in CA-GFP. Due to the position of
the cleavage point within the recognition sequence,
caspase-7 generates a DEVD C-terminus in CA-GFP,
whereas hRV3C protease yields a LEVLFQ C-terminus, re-
sulting in a C-terminal remnant that is two residues longer.
We first investigated the impact of the length of the
C-terminal remnant. We removed Tyr and Lys residues
just before the LEVLFQ sequence (HRA-DYKGFP;
Table 1) to yield a C-terminus of equal length to the
DEVD-containing remnant in CA-GFP, and we did not
observe a significant improvement in signal (data notFIGURE 4 Engineering CA-GFP into an hRV3C
protease-activatable GFP reporter. (A) Construct
LEVLF-GFP is similar to CA-GFP but has a
LEVLFQYGP linker that can be recognized by
hRV3C protease. (B) Whole-cell fluorescence of
LEVLF-GFP cotransformed with empty pET
vector (white), active caspase-7 (black), and
hRV3C protease (gray). Western blot analysis is
shown using an anti-GFP antibody to determine
cleavage efficiency. Thick arrow: full-length
reporter; thin arrow: cleaved reporter. (C)
Comparison of the whole-cell fluorescence of
a spectrum of hRV3C protease-activatable GFP
constructs. Each construct was cotransformed
into E. coli with empty vector (white) or hRV3C
protease (gray). Whole-cell fluorescence was
measured. (D) Comparison of the whole-cell fluo-
rescence of C-terminally truncated GFP reporter
constructs. A stop codon (*) was introduced into
selected GFP reporters to generate GFPs with
different linker remnants. These truncated
reporters were cotransformed with an empty pET
vector and whole-cell fluorescence was measured.
Western blot analysis with anti-GFP antibody is
shown for evaluation of relative expression levels.
(E) Comparison of the signal strengths of CA-
GFP, LEVLF-GFP, DEVLF-GFP, and EEVLF-
GFP in an on-plate fluorescence assay. CA-GFP
was cotransformed with active caspase-7. Other
reporters were cotransformed with hRV3C
protease. The fluorescence of E. coli colonies
coexpressing the reporters and their corresponding
proteases (or empty pET vectors as controls)
was monitored under a long-wavelength UV light.
White-light illumination pictures were taken as
controls.
GFP-Based Reporters of Protease Activity 1611shown). We then focused on the chemical composition of
the remaining linker residues. To increase the reporter
detectability while keeping its specificity against hRV3C
protease, we made a spectrum of variations in the linker
residues and assessed their ability to function as hRV3C
reporters (Fig. 4 C). We were especially interested in the
LEVLFQ linker. The two leucines represent the only
sequence difference between CA-GFP and LEVLF-GFP,
indicating that they play a prominent role in the diminished
fluorescence of the engineered reporter. We replaced the
leucines in LEVLF-GFP with negatively charged or hydro-
philic residues. Replacing the two leucines indeed led
to a significant increase in fluorescent signal in all of the
resulting reporters (Fig. 4 C). Two of our best reporters,
DEVLF-GFP and EEVLF-GFP, showed a strong increase
in fluorescence upon coexpression of hRV3C protease
while still maintaining a recognition site that was sufficient
for robust cleavage, making them the best candidates for
an hRV3C reporter. Other linker variants had either a lower
signal strength or higher background in the dark state.
LEHDF-GFP shows a signal/noise ratio similar to that of
DEVLF-GFP or EEVLF-GFP and an even stronger signal
strength; however, LEHD is a caspase-9 recognized
sequence and therefore is likely to have lower global spec-
ificity than the DEVLF-GFP or EEVLF-GFP reporters.
We next sought to understand the bases of the difference
in fluorescent signal of the various candidate hRV3C
reporters. We hypothesized that the amount of fluorescence
recovery observed could be due to the intrinsic fluorescent
properties of GFP with various C-terminal remnants, as
we previously showed that the ability to fold properly after
removal of the quenching peptide is central to the mecha-
nism of the CA-GFP reporter (12). To probe the influence
of various C-terminal remnants, we introduced stop codons
either after the glutamine in the linker (to mimic the C-
terminus generated by hRV3C cleavage) or before the
phenylalanine (to mimic the length of the remnant in CA-
GFP cleavage by caspase-7; Fig. 4 D). The C-terminal
LEVLFQ remnant strongly suppressed the fluorescent
signal of GFP, likely due to the clustering of four hydro-
phobic residues, which may lead to aggregation and prevent
GFP chromophore maturation. Thus it is clear that one
important aspect in the design of CA-GFP-derived reporters
is the consideration of the C-terminal remnant after
cleavage. To decrease the hydrophobicity of the C-terminal
remnant, we replaced phenylalanine with glycine. As we
anticipated, this improved the fluorescence of the cleaved
reporter, indicating that the presence of the bulky, hydro-
phobic phenylalanine interferes with the fluorescence
recovery of GFP (Fig. 4 C). Unfortunately, replacing the
phenylalanine with glycine also led to increased background
fluorescence in the uncleaved state. Therefore, this substitu-
tion is not necessarily beneficial for generating a better
reporter overall. Replacing phenylalanine with glycine in
a different context could become productive, though,because it leads to diminished recognition by the hRV3C
protease in the LEHDG-GFP reporter while retaining the
recognition sequence for caspase-9 (Fig. 4 C). Thus, it is
clear that one must balance specificity for the protease and
optimal chemical characteristics of the resulting peptide
tail when designing an optimal reporter.
From this panel of variants we sought to identify the
hRV3C reporter with detection properties similar to those
of CA-GFP. In an on-plate assay, E. coli colonies coexpress-
ing DEVLF-GFP or EEVLF-GFP with hRV3C protease
demonstrated clearly improved fluorescence detectability
over that of the original LEVLF-GFP constructs. This level
of fluorescence allows for obvious detection in on-plate
screening applications of the reporter (Fig. 4 E).Engineering various colors of reporters for
multiprotease profiling
To enable simultaneous monitoring of multiple protease
reporters, we took advantage of the spectrum of fluorescent
proteins available. Several color-shifted versions of GFP
result from only a few point mutations, so we hypothesized
that the color of the fluorescent protein in CA-GFP could be
shifted to cyan and yellow versions without disrupting the
mechanism of the dark state. We designed CA-Cerulean
(17) (CA-CerFP) and CA-Citrine (18) (CA-CitFP) versions
of our reporter, both of which still contain the caspase-7
recognition sequence DEVD in the linker (Fig. 5 A). These
fluorescent proteins have minimally overlapping excitation
and emission wavelengths, and both have the highest
quantum yield for their color class (19), giving them the
most potential for the best signal/noise ratio. Both versions
are in a dark state when coexpressed in E. coli with the inac-
tive caspase-7 C186A and have a significant increase in
fluorescence when coexpressed with active caspase-7
(Fig. 5 B).
Red-shifted fluorescent proteins are becoming more
widely used because their emission properties fall within
the critical window for whole-organism imaging due to
the deep-tissue penetrance for red wavelengths of light
and the absence of background autofluorescence in tissues
in this spectral region. Red fluorescent proteins (RFPs) are
derived from Entacmaea quadricolor (20). Although they
have a different protein sequence compared with GFPs
from Aequorea, the two families show strikingly similar
protein folding. We selected mNeptune (21) for its improved
brightness and spectral properties in the near-infrared
region, which are increasing its popularity for in vivo
imaging. In our first design of CA-mNeptune, we fused
the M2 peptide through a linker identical to that used in
CA-GFP to the C-terminus of mNeptune; however, this
protein showed a considerable level of fluorescence
before cleavage. Because we had already observed that
an N-terminal fusion of M2 to GFP resulted in a dark
state before cleavage (nCA-GFP (12)), we reasoned thatBiophysical Journal 104(7) 1605–1614
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FIGURE 5 (A) Design of CA-CerFP, CA-CitFP, and CA-mNeptune.
The constructs for CA-CerFP and CA-CitFP are identical to CA-GFP
with the exception of the color-shifting point mutations in the GFP
portion of the reporter. CA-mNeptune has the quenching peptide fused
to the N-terminus of the mNeptune fluorescent protein derived from
Entacmaea. (B) Increase in relative fluorescence of each reporter in
response to active caspase-7 (gray) or an inactivated version of caspase-7
(C186A, white) in which the active-site cysteine nucleophile has been
replaced by alanine. (C) The properties of each reporter, including the
increase in fluorescence, the relative brightness (which was calculated as
the fluorescence of each reporter relative to CA-GFP, with the total fluores-
cence yield of CA-GFP being normalized to one), the reported quantum
yield (17,18,21,36), and the optimal excitation and emission wavelengths
for each fluorescent protein are shown.
1612 Wu et al.mNeptune might be similarly quenched from the
N-terminus. The resulting N-terminal fusion, CA-mNep-
tune, has a very low fluorescent background. Therefore,
although the overall fluorescence intensity is low, cleavage
of CA-mNeptune by active caspase-7 results in a >30-
fold increase in signal in E. coli (Fig. 5 B), demonstrating
that the quenching peptide works on other nonGFP-derived
fluorescent proteins and at various locations.
All three reporters can clearly be activated and show an
improved signal/noise ratio relative to that of comparable
reporters (22–30). Nevertheless, the CA-mNeptune, CA-
CerFP, and CA-CitFP reporters showed a lower overall
fluorescence intensity and a lower relative increase in fluo-
rescence over the background than CA-GFP (Fig. 5 C). We
hypothesize that this is due not only to differences in the pub-
lished quantum yields of the mNeptune (21), Cerulean (17),
and Citrine (18) variants but also to differences in the folding
kinetics of the different fluorescent proteins (12,31,32).Biophysical Journal 104(7) 1605–1614The four fluorescent proteins described here—GFP,
Cerulean, Citrine, and mNeptune—constitute a panel of
spectrally distinct fluorescent proteins that have been indi-
vidually engineered for improved brightness in their respec-
tive families of color (cyan, yellow, and red). Each can be
used individually to monitor specific proteolytic events or
together to watch several events using multichannel
imaging. CA-mNeptune in particular has the potential for
effective use in whole-animal models, because mNeptune’s
fluorescence falls in the near-infrared window that mini-
mizes background from water and hemoglobin in tissue.
The fact that the quenching peptide used in CA-GFP and
its derivatives can effectively quench fluorescence in GFP,
Cerulean, Citrine, and mNeptune suggests that this type of
reporter may be feasible with other even more distantly
related fluorescent proteins, such as IRFP (33).CONCLUSIONS
CA-GFP has proved to be a useful and effective reporter of
caspase activity and apoptosis in a variety of systems. We
have now shown that CA-GFP can be engineered to change
the protease specificity and the color of fluorescence. With
this expansion of the color palette, these new reporters can
ultimately be used in multiplex microscopy, fluorescence-
activated cell sorting, and other applications that require
the detection of protease activity changes. Although chal-
lenges remain in the effort to engineer optimal reporters
for additional enzymes, in this work we have demonstrated
a series of engineering steps by which new reporters can be
developed. One challenge for any protease reporter is to
achieve specificity for one protease over other related prote-
ases. Of course, the specificity of any synthetic reporter is
limited by the inherent properties of the parent protease it
is designed to monitor. The most important factor in the
design is the unique characteristics of the protease. One
must consider all potential processing sites, as well as the
propensity of the protease to cleave in specific secondary
structure conformations, such as loops. The ability of
multiple proteases to cleave a similar substrate is also
a major limitation; for example, LEHDF-GFP, which can
be cleaved by hRV3C protease, is also the substrate for
caspase-9. Potentially, one could ameliorate this overlap-
ping specificity by using small-molecule inhibitors for one
class of proteases while fluorescently monitoring the
activity of the desired protein.
To identify the activity of a specific caspase indepen-
dently of other caspases, it is imperative to ensure that
the reporter only responds effectively to the selected
protease. We may be able to use the ability of caspases
to cleave secondary sites (as we found in caspase-6) to
our advantage if we can design a reporter that is activated
in the presence of a particular caspase but is inactivated
by secondary cleavage if multiple caspases are active.
This dual recognition, combined with multicolor reporting,
GFP-Based Reporters of Protease Activity 1613could be applied to increase the detectability of a specific
caspase, such as caspase-6, in both apoptotic and nonapop-
totic events. When caspase-6 is active, it will increase
the fluorescence of the caspase-6 reporter and at the same
time repress the signal from a caspase-7 reporter. This
reporter would also necessitate a multicolored reporter
system in which multiple signals could be monitored at
the same time.
We observed that, especially in the case of hRV3C
protease-activatable GFP reporters, the reported optimized
substrate sequence was often not the one that gave the
best signal. The size and active-site conformations of
some proteases, as well as the accessibility of the cleavable
linker in the reporter, could all contribute to the interaction
between them and affect the efficiency of the reporter.
Emerging data suggest that the small peptide substrates
that have been widely used to characterize protease activity
may not accurately reflect the actual selectivity properties of
proteases. When a protease is presented with a protein
substrate, the steric interactions and kinetics are signifi-
cantly different from those observed with a peptide
substrate. This may prove to be advantageous for the CA-
GFP family of reporters, which are protein rather than
peptide substrates. Although caspase-3 and -7 share the
same P1–P4 specificity, the P6, P5, P20, and P30 residues
also contribute to caspase-7 specificity in substrates (34),
for example. The small tetrapeptide substrates frequently
used in caspase activity measurement and profiling might
lead one to overlook the contribution of exosites. Boucher
and co-workers (35) identified a caspase-7 exosite that is
critical for substrate recognition and differentiation of cas-
pase-7 substrates from caspase-3 substrates. The fact that
CA-GFP is a protein-based reporter provides an advantage
in designing specificity, particularly as more details about
the extended recognition preferences of caspases come to
light. In summary, we have demonstrated that CA-GFP is
a modular platform that allows substitution of both the fluo-
rescent and recognition modules. This modular construction
allows one to tune the reporter to meet a wide range of
desired specifications.SUPPORTING MATERIAL
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